Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol tartrate nasal spray for breakthrough cancer pain
ChiCTR2100044620Phase 4Recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butorphanol and morphine in cancer pain (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Pain score. Started Mar 2021; status: recruiting.
02
Drugs
butorphanolmorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2100044620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044620.